The following communication, dated 16 May 2019, from
the delegation of the European Union to the Chairperson of the Dispute
Settlement Body, is circulated pursuant to Article 21.6 of the DSU EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum